Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or ...

AstraZeneca boosts CEO Soriot's pay to about $24 million for 2025 | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]AstraZeneca CEO Pascal Soriot attends an announcement about lowering U.S. drug prices, at the White House in Washington, D.C., U.S., October 10, 2025. REUTERS/Kent Nishimura/File Photo [Purchase Licensing Rights, opens new tab]- Companies[AstraZeneca PLC]FollowFeb 24 (Reuters) - AstraZeneca [(AZN.L), opens new tab] Chie ...

Hims & Hers Health, Inc. ( HIMS ) reported a 4Q25 GAAP earnings per share of $0.08, a figure that beat expectations by about $0.03. Revenue came in at $617.82 million, essentially in line with forecasts, and showed us I hold a Master's degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation f ...

Newport Beach, CA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a U.S.-based independent power producer specializing in utility-scale battery energy storage systems (BESS), today announced that its Redbird project, a 100 MW / 400 MWh battery energy storage system located in Texas, has been formally approved for participation under its Joint Development Agreement (JDA) and that the Company has selected Eos Energy Enterprises, Inc.'s (NASDAQ: EOSE) Z3™ zinc-bas ...

Primary endpoint met with statistically significant improvement (mean change of +2.13; p<0.001) on the Microcystic Lymphatic Malformation Investigator Global Assessment (mLM-IGA) Achieved statistical significance on pre-specified key secondary endpoint (p<0.001) and all four secondary efficacy endpoints (all p<0.001) 95% of trial participants aged ≥ 6 who completed the efficacy evaluation period improved on the mLM-IGA at Week 24 86% of trial participants aged ≥ 6 who completed the efficacy evaluation perio ...

Combined Company will Continue as CECO Environmental Under CEO Todd Gleason Adds Highly Complementary Industrial Process Heating and Thermal Management Capabilities Transaction Funded with Stock and Cash Expected to Deliver a Platform with Sustained Double-Digit Growth and Enhanced Financial Profile CECO Today Separately Released Fourth Quarter and Full Year 2025 Results; Company to Host Investor Call at 8:30 AM ET ADDISON, Texas and AUSTIN, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- CECO Environmental Corp. ...

Adjusted EBITDA growth and low double-digit Adjusted EPS growth, all starting in 2026Financial HighlightsFourth Quarter Results(dollars in millions, except per share amounts)20252024Change (%)Organic CC Growth(1) (%)Pet Health$489$43911 %9 %Farm Animal$640$57012 %10 %Cattle$296$25317 %15 %Poultry$237$21311 %8 %Swine$107$1043 %1 %Contract Manufacturing and Other (2)$15$1136 %Total Revenue$1,144$1,02012 %9 %Gross Profit$589$51913 %Reported Net Loss$(276)$(8)NMAdjusted EBITDA$189$1777 %Reported EPS$(0.56)$(0.0 ...

I publish my best ideas and top coverage on the Growth Stock Forum. If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely.Our biotech Top Picks increased 137.6% last year with a 37.2% CAGR since 2017, along with a mid-20s CAGR for our core portfolio LTGP (CAGR performance as of Feb 20, 2026).To receive e-mail notifications for my public articles and blogs, ...

Frontier Biotechnologies strikes up to $1 billion deal with GSK | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration [Purchase Licensing Rights, opens new tab]Feb 24 - Frontier Biotechnologies [(688221.SS), opens new tab] said on Tuesday it has struck a deal with GSK [(GSK.L), opens new tab], granting the British drugmaker worldwide ...

Botin to set out cost savings from Santander digital drive after deal spree | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]FILE PHOTO: Ana Botin, head of Santander, speaks during the ReutersNEXT Newsmaker event in New York City, New York, U.S., November 9, 2023. REUTERS/Brendan McDermid/File Photo [Purchase Licensing Rights, opens new tab]- Companies- Summary- Some investors, analysts prefer growth to higher payouts- Pivots toward ...